Breast cancer is a heterogeneous disease that can be classified into diverse subtypes with distinct biology and prognosis. The purpose of this study is to compare clinicopathological features and prognostic of patients with Triple Negative Breast Cancer (TNBC) and non-TNBC. Clinicopathological features and prognosis of 266 patients from north Morocco (56 TNBC and 210 non-TNBC) were evaluated using SPSS 20 software. The incidence of TNBC was 21%. Comparedwith non-TNBC, TNBC patients tend to be younger at diagnosis and had slightly larger tumors and higher stage. Higher histological grade was strongly associated with TNBC. Lymph nodes and histological type were similar in the two groups. Bone was the most frequently metastatic site in all bre...
Objective: To analyze the clinical, pathological, and sociodemographic aspects between triple-negati...
Background: This study assesses outcome in terms of disease-free survival (DFS) and overall survival...
Much research has focused on finding novel prognostic biomarkers for triple negative breast cancer (...
Introduction: Breast cancer is the second most common cancer worldwide (1.3 million cases, 10.9%) an...
AbstractObjectiveThis study aimed at determination of the MRI predictors of triple negative breast c...
BACKGROUND AND OBJECTIVESTriple-negative breast cancer (TNBC) has a poor prognosis and overall survi...
Abstract Background Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor...
Purpose: Triple-negative breast cancer (TNBC) has some distinctive features. The aim of the study wa...
Introduction: Triple-negative breast cancer (TNBC) is characterized by the lack of estrogen receptor...
AbstractAimThe aim of this study was to determine the incidence of TNBC in Kuwait, to analyze the cl...
Background: Triple negative breast cancers (TNBC) are defined by absence of estrogen and progesteron...
Objectives: To compare the risk factors and clinico-pathological features of Triple Negative Breast ...
Background: Worldwide breast cancer is the most frequently diagnosed life threatening cancer in wome...
Breast cancer is the most common cancer among Malaysian women. There are many prognostic factors con...
Objective: To observe triple negative breast cancer (TNBC) characteristics in three hospitals locate...
Objective: To analyze the clinical, pathological, and sociodemographic aspects between triple-negati...
Background: This study assesses outcome in terms of disease-free survival (DFS) and overall survival...
Much research has focused on finding novel prognostic biomarkers for triple negative breast cancer (...
Introduction: Breast cancer is the second most common cancer worldwide (1.3 million cases, 10.9%) an...
AbstractObjectiveThis study aimed at determination of the MRI predictors of triple negative breast c...
BACKGROUND AND OBJECTIVESTriple-negative breast cancer (TNBC) has a poor prognosis and overall survi...
Abstract Background Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor...
Purpose: Triple-negative breast cancer (TNBC) has some distinctive features. The aim of the study wa...
Introduction: Triple-negative breast cancer (TNBC) is characterized by the lack of estrogen receptor...
AbstractAimThe aim of this study was to determine the incidence of TNBC in Kuwait, to analyze the cl...
Background: Triple negative breast cancers (TNBC) are defined by absence of estrogen and progesteron...
Objectives: To compare the risk factors and clinico-pathological features of Triple Negative Breast ...
Background: Worldwide breast cancer is the most frequently diagnosed life threatening cancer in wome...
Breast cancer is the most common cancer among Malaysian women. There are many prognostic factors con...
Objective: To observe triple negative breast cancer (TNBC) characteristics in three hospitals locate...
Objective: To analyze the clinical, pathological, and sociodemographic aspects between triple-negati...
Background: This study assesses outcome in terms of disease-free survival (DFS) and overall survival...
Much research has focused on finding novel prognostic biomarkers for triple negative breast cancer (...